What Humana’s Medicare Advantage Warning Could Mean For Members

The company has signaled pressure in its Medicare Advantage business, raising questions about future benefits, costs and plan choices.

Humana’s latest warning about its Medicare Advantage business does not mean every member will see immediate changes, but it does signal that the company is under pressure to balance rising medical costs, government payments and plan profitability as it prepares future benefits.

The company reported first-quarter 2026 results this week that beat profit expectations, but it kept its full-year adjusted profit forecast unchanged. Humana said its insurance benefit ratio, a measure of how much premium revenue is spent on medical care, was 89.4% in the quarter and reaffirmed a full-year insurance segment benefit ratio outlook of 92.75%, plus or minus 25 basis points.

For Medicare Advantage members, the most important issue is what Humana may do in future plan years. According to reports, the company cited continued pressure from a gap between Medicare Advantage reimbursements and the cost of care, and said it would adjust benefits to maintain margins.

Medicare Advantage plans are private insurance plans approved by Medicare. They often combine hospital, medical and prescription drug coverage, and may include extras such as dental, vision, hearing, fitness or transportation benefits. Those added benefits, along with premiums, copays, deductibles, drug formularies and provider networks, can change from one plan year to the next.

That means the warning matters most when members receive official plan materials, not simply when the company reports earnings. Possible changes could include higher out-of-pocket costs, different copays, changes to supplemental benefits, narrower provider networks, altered drug coverage or changes in where certain plans are offered. Details have not yet been finalized for every member, and changes vary by county, plan type and contract.

Humana has also been dealing with lower Medicare Advantage Star Ratings, which affect federal bonus payments. In its first-quarter materials, the company said the number of its Medicare Advantage plans rated four stars or higher had declined, and that a court rejected its challenge to the 2025 ratings, although Humana has appealed. The company said there can be no assurance it will ultimately prevail.

For a current member, the practical question is whether your specific plan changes. A companywide warning does not automatically mean your doctor, drug coverage or extra benefits will change. But it is a reason to read all plan notices carefully and compare options during Medicare’s annual enrollment period.

Members should watch for the Annual Notice of Change, Evidence of Coverage and any separate notices from Humana or Medicare. Those documents should spell out changes to premiums, maximum out-of-pocket limits, prescription drug tiers, prior authorization rules, pharmacy networks, doctor and hospital networks, and supplemental benefits.

People who rely on regular prescriptions, specialists, home health services or specific hospitals may want to check those items first. Family caregivers may also want to review whether a loved one’s preferred doctors and medications remain covered before assuming the same plan is still the best fit.

What happens next will depend on Humana’s 2027 plan filings, future Medicare payment rules, medical cost patterns and the outcome of its Star Ratings appeal. Until official plan documents are released, members should treat the warning as an early signal to review coverage closely, not as confirmation that a particular benefit will be reduced.